GH1 and obesity due to melanocortin 4 receptor deficiency: Tamboli et al. [10] studied the central and peripheral responses to ghrelin in obesity and during the early period after RYGB in humans and found that ghrelin-stimulated GH secretion is attenuated in obesity, and this effect improves 2 weeks after RYGB, but peripheral insulin sensitivity is not altered.